ATTBF Stock UPDATES Abattis Bioceuticals (ATTBF) 0.3462 09/13/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Abattis Bioceuticals (ATTBF) 0.3462 $ATTBF

Abattis' Phytalab Receives Cannabis Lab Certification in Washington
ACCESSWIRE - Mon Sep 08, 7:07AM CDT
Vancouver, BC / ACCESSWIRE / September 8th, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that Phytalytics LLC. ("Phytalab.com" , its 51% controlled US subsidiary, has received provisional certification from the Washington State Liquor Control Board. This milestone enables the lab to legally offer service to the new legal Cannabis industry.

Abattis Announces Grant of Stock Options
ACCESSWIRE - Wed Aug 13, 7:43PM CDT
Vancouver, BC / ACCESSWIRE / August 13, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), the Company is pleased to announce that, in compliance with the Company's option plan, the Company has granted 455,000 incentive stock options to certain of its directors, officers and consultants, with each option being exercisable into a common share of Abattis at $0.43 per share for a period of five years.

Abattis Appoints Jason Anderson as VP of Finance
ACCESSWIRE - Fri Aug 08, 3:47PM CDT
Vancouver, BC / ACCESSWIRE / August 8, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, patented equipment, and consulting services to medicinal markets in North American, today announced the appointment of Jason Anderson, CA, CFA as Vice President of Finance.

Abattis' Biocube Licenses Terrasphere Vertical Farming Technology
ACCESSWIRE - Wed Aug 06, 8:07AM CDT
Vancouver, BC / ACCESSWIRE / August 6, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that Biocube Green Grow Systems Corp. ("Biocube" , its wholly owned subsidiary, entered into a worldwide non-exclusive licensing agreement with TerraSphere Systems LLC ("TerraSphere" for the company's proprietary and patented vertical farming technology. The TerraSphere license complements Biocube's previously announced sublicensing agreement for Vertical Design Ltd.'s ("VDL" vertical farming technology.

Abattis Enters Into US$5 Million Standby Equity Purchase Agreement with Kodiak Capital Group, LLC
ACCESSWIRE - Tue Aug 05, 8:11AM CDT
Vancouver, BC / ACCESSWIRE / August 5, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, including medical marihuana, announced that it has entered into a US$5 million standby equity financing agreement with Kodiak Capital Group, LLC, a Newport Beach, CA-based institutional investor. The Company has agreed to file a registration statement with the U.S. Securities & Exchange Commission ("SEC" covering the Abattis shares that may be issued to Kodiak under this financing. After the SEC has declared the registration statement related to the transaction effective, the Company has the right at its sole discretion over a period of one year to sell up to US$5 million of common shares to Kodiak.

Abattis Sub-Licenses Vertical Grow Systems to Biocube
ACCESSWIRE - Thu Jul 31, 7:04AM CDT
Vancouver, BC / ACCESSWIRE / July 31, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), today announced that it has entered into a sub-licensing agreement with its subsidiary, Biocube Green Grow Systems Corp. ("Biocube" , for the non-exclusive use of Vertical Design Ltd.'s ("VDL" vertical growing systems for which Abattis owns certain exclusive worldwide rights. Under the terms of the agreement, Biocube has agreed to pay Abattis certain licensing fees and ongoing royalties for products grown and sold within the pharmaceutical, nutraceutical, cosmetic, and wellness markets. The company also wishes to clarify recent confusion about the ownership of the rights and uses to the VDL growing technology that has been created by Affinor Growers, (CSE: AFI) (OTCQB: RSSFF) the parent of VDL.

Abattis Makes History as First Marijuana Stock to List on Prestigious OTCQX
ACCESSWIRE - Tue Jul 15, 7:00AM CDT
Whitefish, MT / July 15, 2014 / Abattis Bioceuticals Corp. (OTC: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary products and services to the North American cannabis industry, added to its growing list of accomplishments by becoming the first cannabis stock to list on the prestigious OTCQX tier of the OTC Markets on Monday, July 14, 2014.

Cannabis Stocks Move Higher as Washington State Pot Sales Begin
ACCESSWIRE - Mon Jul 14, 8:30AM CDT
WHITEFISH, MT / July 14, 2014 / The Marijuana Index(TM) moved higher last week in the aggregate, despite a 13% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares and a roughly 1.5% drop in Medbox Inc. (OTC: MDBX) shares, which comprise about half of the weighted index.

Abattis Begins Trading On The OTCQX
ACCESSWIRE - Mon Jul 14, 5:17AM CDT
Vancouver, BC / ACCESSWIRE / July 14, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that it began trading on the OTCQX marketplace.

OTC Markets Group Welcomes Abattis Bioceuticals to OTCQX®
PR Newswire - Fri Jul 11, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced that Abattis Bioceuticals Corp. (CSE: ATT; OTCQX: ATTBF), a specialty biotechnology company, has qualified to trade on OTCQX®, the best marketplace.

Abattis Information Available on S&P Capital IQ
ACCESSWIRE - Mon Jul 07, 12:21AM CDT
Vancouver, BC / ACCESSWIRE / July 6, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio---similar compounds, equipment, and consulting services to North American medicinal markets, today announced that its company information would be made available via S&P Capital IQ Corporation Record's Listing Program. This is one of the final steps in the Company elevating to the OTC QX in the upcoming months.

Correction To Earlier News: Abattis Names Brazos Minshew The Next President Of Biocell
ACCESSWIRE - Wed Jul 02, 10:53PM CDT
Vancouver, BC / ACCESSWIRE / July 02, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Brazos Minshew, Chief Executive Officer of Samuel J. Brant, LLC and would like to issue the following correction.

Abattis Names Brazos Minshew The Next President Of Biocell
ACCESSWIRE - Wed Jul 02, 7:23PM CDT
Vancouver, BC / ACCESSWIRE / July 02, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Brazos Minshew, Chief Executive Officer of Samuel J. Brant, LLC, former Chief Science Officer of TriVita, Inc., former Chief Executive Officer of Therapy Alternatives and Director of Marketing for Tiena Health, will assume the role of President of BioCell Labs, a wholly-owned subsidiary of Abattis Bioceuticals Corp. effective July 1, 2014. He will succeed Mike Withrow, who is resigning his role of President at BioCell to focus on leadership as Chief Executive Officer of Abattis Bioceuticals Corp. He will remain as Chairman of BioCell.

Marijuana Sector Positioned to Move Higher as FDA Reviews Drug's Status
ACCESSWIRE - Mon Jun 30, 8:32AM CDT
WHITEFISH, MT / June 30, 2014 / The Marijuana Index(TM) traded marginally lower last week after MedBox Inc. (OTC: MDBX) and CannaVEST Corp.'s (OTC: CANV) moves lower offset GW Pharmaceuticals plc's (NASDAQ: GWPH) modest gains.

Abattis Bioceuticals to be Featured on CEO Clips Airing on BNN
ACCESSWIRE - Fri Jun 27, 3:55PM CDT
Vancouver, BC / ACCESSWIRE / June 27, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC Pink: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that CEO Clips will be running a series of commercials on Canada's Business News Network ("BNN" advertising the Company's upcoming BTV Business Television segment are to be shown on July 19th and July 20th.

Abattis Bioceuticals Receives Breakthrough Nitric Oxide WIPO Patent Publication
ACCESSWIRE - Mon Jun 23, 4:57PM CDT
Vancouver, BC / ACCESSWIRE / June 23, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC Pink: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that its wholly-owned subsidiary, BioCell Laboratories, Inc. ("BioCell" , was awarded an International Patent for refining the optimum natural sources of nitric oxide in the human body.

Abattis Bioceuticals Adopts New Policies, Changes Auditor & Adds New Board Members at Annual General Meeting of Shareholders
ACCESSWIRE - Thu Jun 19, 9:34PM CDT
Vancouver, BC / ACCESSWIRE/ June 19, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC Pink: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that its previous Board has been re-elected and two industry experts have been added to the Company's Board of Directors and shareholders have also approved the adoption of new policies at the Company's Annual General Meeting of Shareholders ("AGM" held on June 18, 2014.

Novus (NDEV) Aims to Fill Key Void in Cannabis Industry
ACCESSWIRE - Mon Jun 16, 7:04AM CDT
Whitefish, MT / June 16, 2014 / The U.S. legal cannabis industry is expected to reach $2.34 billion in size by the end of the year, according to ArcView Market Research. With additional states expected to legalize the drug over the next five years, the same group believes that the U.S. industry could reach $10.2 billion in size by 2018. These growth rates have attracted both investors and lawmakers interested in shoring up tax revenue.

Abattis Launches a New Corporate Website
ACCESSWIRE - Fri Jun 13, 3:38PM CDT
Vancouver, BC / ACCESSWIRE / June 13, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced the launch of its newly redesigned corporate website.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

PetSmart Charities Adds Strategy Role for Pet Families

Updated Category News Views 110

A pet bowl can become a crisis marker faster than people admit. Housing trouble, empty cupboards, a hurricane, or an unaffordable veterinary bill can turn a loved animal into one more impossible responsibility. That is the uncomfortable reality behind PetSmart Charities' decision to create a vice president of strategic programs and partnerships role and appoint Heather...

Continue Reading
Winter Leaks Can Lock In Tarrant Sewer Costs for 2027

Updated Category News Views 97

Silent toilet seepage has a nasty habit of turning winter into a twelve-month utility hangover. Tarrant County homeowners are heading into the period when some local cities use household water consumption to calculate residential sewer charges for the following year. That is not the sort of detail anybody enjoys thinking about during the holidays, but ignoring it can be...

Continue Reading
Gildan Lawsuit Puts Revenue Quality Under a Harsh Lens

Updated Category News Views 84

Inventory can hide a multitude of sins until somebody counts the boxes, and that is the ugly question hanging over Gildan Activewear. A federal securities class action alleges the company inflated reported sales and organic-growth figures by pushing excess product into wholesaler and distributor channels. Those are allegations, not findings of fact, and investors ought to...

Continue Reading
RMT’s 12.4% Discount Still Demands a Much Harder Look

Updated Category News Views 102

A $1.84 gap is staring RMT shareholders right in the face. As of October 31, 2026, Royce Micro-Cap Trust carried a net asset value of $14.82 per share while the market price sat at $12.98. That is roughly a 12.4% discount to NAV, and closed-end fund investors should never wave off a spread like that with a lazy shrug. It may be opportunity. It may also be the market...

Continue Reading
Mace Consult Bets on Sawaya for Americas Expansion

Updated Category News Views 151

Concrete, tunnel bores, and data-center campuses rarely wait politely for a leadership transition. Mace Consult has named Mario Sawaya president of its Americas business, and the hire reads less like ceremonial executive shuffling than a deliberate move toward the thickest part of the capital-spending map. Sawaya brings more than 20 years of experience leading...

Continue Reading
AltaPointe PATH Outreach Puts Housing Waits in Focus

Updated Category News Views 84

Two years is a brutal length of time to ask somebody without stable housing to wait for an income-based apartment. That number hangs over AltaPointe Health's PATH program in Mobile, Alabama, and it ought to. The organization helped 16 people secure permanent housing in the past fiscal year, a figure that can look small if somebody is just skimming a report. It looks very...

Continue Reading
Software-Defined Cars Put $310 Billion in Play by 2035

Updated Category News Views 111

Cars are becoming rolling computers, and that changes who gets paid. Market Growth Reports projects the software-defined vehicle market will rise from $56.94 billion to $310.46 billion by 2035, a 20.74% compound annual growth rate. That is a loud number, no question. Still, investors ought to treat any long-range market forecast like a map, not a mortgage deed. The...

Continue Reading
Oman’s Dhofar II Wind Deal Clears Financing Hurdle

Updated Category News Views 95

Dhofar’s next wind farm has crossed the line that matters: financial close. That is less glamorous than turbines spinning against an Omani skyline, but it is the point where a project stops being an attractive deck and becomes a real contractual obligation. Sembcorp Utilities, alongside OQ Alternative Energy through Naseem Dhofar SAOC, has brought the 125-megawatt...

Continue Reading
RBC Signals Gets $10 Million to Push Space Infrastructure

Updated Category News Views 135

Ground stations are the unglamorous plumbing of the space economy, and somebody finally put fresh capital behind the wrench. RBC Signals says it has received a $10 million strategic growth investment led by Washington Harbour Partners, aimed at enlarging its government-services operation and pushing several newer space-connectivity tools toward commercial use. This is a...

Continue Reading
Vanguard's Digital Win Matters More Than a Trophy

Updated Category News Views 182

A wealth manager’s website rarely earns applause, but a bad one can sure as hell lose trust fast. Vanguard’s move to No. 1 from No. 3 in the 2025 ranking for advised-investor website satisfaction is worth noticing because it hits the unglamorous part of wealth management that clients actually live with: checking accounts, understanding a plan, moving cash, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Siebert Financial Secures $100 Million for Innovation and Growth

Updated Category News Views 177

Siebert Financial Initiates Strategic Funding Initiative Siebert Financial Corp. (NASDAQ: SIEB) has taken a significant step by announcing the effective declaration of its shelf registration statement on Form S-3 by the SEC. This move permits the company to raise an impressive $100 million through a variety of securities offerings. Enhancing Financial Flexibility and...

Continue Reading
BTQ Technologies Launches Léonne: A New Era in Blockchain Security

Updated Category News Views 250

BTQ Technologies Introduces Léonne Framework BTQ Technologies Corp. is making waves in the blockchain industry with the unveiling of Léonne, a groundbreaking consensus framework that integrates trust modeling, network analysis, and quantum-resistant cryptography into a cohesive and modular system. This innovative approach positions Léonne as the first of its kind,...

Continue Reading
Annovis Bio Welcomes Matthew Peterson, Ph.D., to Lead Clinical Trials

Updated Category News Views 231

Matthew Peterson, Ph.D., Joins Annovis Bio as Senior Clinical Scientist Annovis Bio Inc. (NYSE: ANVS) is making headlines with the recent addition of Dr. Matthew Peterson as Senior Clinical Scientist. This strategic appointment comes at a critical juncture for the company, which is dedicated to developing innovative therapies targeting neurodegenerative disorders...

Continue Reading
Ironwood's Strategic Shift: Apraglutide Development Focus

Updated Category News Views 252

Ironwood Pharmaceuticals Outlines Strategic Focus on Apraglutide Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a leading biotechnology company committed to developing innovative therapies for gastrointestinal and rare diseases, has announced a profound strategic shift towards advancing apraglutide, specifically aimed at treating patients with short bowel syndrome (SBS)...

Continue Reading
Chamberlain Group Elevates Home Security with Innovative Smart Lock

Updated Category News Views 341

Chamberlain Group Unveils the Next Generation of Home Security In a groundbreaking move, Chamberlain Group (CG) has introduced the myQ Secure View 3-in-1 Smart Lock, a device that not only acts as a smart lock but also integrates a doorbell and camera. This innovative product marks a significant shift for the company as it extends its reach from garage door innovations to...

Continue Reading